Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2Phase 4 1Phase 3 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Other 2Gastrointestinal 2Gynecologic 1

Conditions

Ovarian Neoplasms 322Uterine Cervical Neoplasms 131Endometrial Neoplasms 107Breast Neoplasms 98Carcinoma, Non-Small-Cell Lung 85Fallopian Tube Neoplasms 76Colorectal Neoplasms 74Carcinoma, Ovarian Epithelial 70Neoplasms 63Pancreatic Neoplasms 62Stomach Neoplasms 59Melanoma 57Triple Negative Breast Neoplasms 49Neoplasm Metastasis 49Squamous Cell Carcinoma of Head and Neck 43Prostatic Neoplasms 42Lung Neoplasms 41Esophageal Neoplasms 40Head and Neck Neoplasms 39Urinary Bladder Neoplasms 32Carcinoma, Renal Cell 31Sarcoma 29Recurrence 27Small Cell Lung Carcinoma 26Colonic Neoplasms 25Carcinoma, Hepatocellular 24Carcinoma, Transitional Cell 20Uterine Neoplasms 16Peritoneal Neoplasms 15Mesothelioma 15

Interventions

Paclitaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Intestinal Obstruction × Gynecologic × Clear all
NCT01083537 2019-02-15

Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction

University Health Network, Toronto

Phase 1/2 Terminated
1 enrolled
Gynecologic

Fallopian Tube Neoplasms, Intestinal Obstruction, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡